Product Added to Cart!
Acetyl-D-leucine|02618|19764-30-8

Acetyl-D-leucine

$626.20

FREE
SHIPPING

100% MONEY
BACK GUARANTEE

ONLINE
SUPPORT 24/7

Available on backorder. No lead time available. Please request a quote.
Sku CI02618_250_G
Chem Impex
Get Bulk Quote

Product Information

Product Name
Acetyl-D-leucine
Brand Name
Chem Impex
Product Number
02618
CAS
19764-30-8
Certificate of Analysis (COA)​
COA not found

General Information

PubChem CID
1241420
IUPAC Name
(2R)-2-acetamido-4-methylpentanoic acid
InChI Key
WXNXCEHXYPACJF-SSDOTTSWSA-N
SMILES
CC(C)CC@H(C(=O)O)NC(=O)C

Description

Acetyl-D-leucine is widely utilized in research focused on:

Neurological Research: This compound is studied for its potential neuroprotective effects, particularly in conditions like Alzheimer's disease, where it may help in reducing cognitive decline.

Pharmaceutical Development: Used as a building block in the synthesis of pharmaceuticals, it aids in the development of drugs targeting metabolic disorders.

Sports Medicine: Athletes and trainers explore its benefits for muscle recovery and performance enhancement, as it may assist in protein synthesis.

Biochemical Studies: Researchers utilize it in studies of amino acid metabolism, helping to understand its role in various biochemical pathways.

Dietary Supplements: It is incorporated into nutritional products aimed at improving muscle mass and overall health, appealing to fitness enthusiasts.

References Data Source From Pubchem

Non-ribosomal peptide cyclase-directed chemoenzymatic synthesis of lariat lipopeptides
Publication Name: Nature Chemistry
Publication Date: 2025-11-04
DOI: 10.1038/s41557-025-01979-6

The Latest Developments for the Treatment of Ataxia Telangiectasia: A Narrative Review
Publication Name: Cerebellum (London, England)
Publication Date: 2024-09-27
DOI: 10.1007/s12311-024-01746-2

N-acetyl-L-leucine for Niemann-Pick type C: a multinational double-blind randomized placebo-controlled crossover study
Publication Name: Trials
Publication Date: 2023-05-29
DOI: 10.1186/s13063-023-07399-6

A master protocol to investigate a novel therapy acetyl-l-leucine for three ultra-rare neurodegenerative diseases: Niemann-Pick type C, the GM2 gangliosidoses, and ataxia telangiectasia
Publication Name: Trials
Publication Date: 2021-01-22
DOI: 10.1186/s13063-020-05009-3

Catalytic properties of aminoacylase of strain Rhodococcus armeniensis AM6.1
Publication Name: Applied Biochemistry and Microbiology
Publication Date: 2016-05-19
DOI: 10.1134/s0003683816030029